AN OPEN LABEL PROSPECTIVE STUDY TO EXPLORE THE EFFICACY OF IPECACUANHA IN CASES OF BRONCHIAL ASTHMA - CASE SERIES

Abstract

An estimated 300 million people worldwide suffer from bronchial asthma, which remains a significant global health concern. Chronic airway inflammation, airway hyperresponsiveness, and reversible airflow limitation are the hallmarks of this diverse respiratory condition.